Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Metabolic syndrome in primary aldosteronism and essential hypertension: Relationship to adiponectin gene variants
Nutrition, Metabolism & Cardiovascular Diseases, 06/05/09
Ronconi V et al. – Data confirm a higher prevalence of metabolic syndrome among pts with primary aldosteronism (PA) vs matched essential hypertensive (EH) pts. Genetic analysis of T45G and G276T adiponectin gene polymorphisms showed that, genotypes 45G/G+G/T have a protective role on metabolic complications, but the genotype 276T/T defined PA and EH pts with a worse metabolic profile.
Methods- Study of whether metabolic syndrome represents a common feature in PA pts vs EH pts
- Study of the impact of 2 common adiponectin gene variants on parameters of metabolic syndrome
- Metabolic syndrome defined by ATPIII criteria
- Subjects: 89 PA pts; 164 matched EH pts
- Detection of 2 adiponectin gene single nucleotide polymorphisms, T45G and G276T, in all PA pts and in 135 EH pts
- PA pts had higher prevalence of metabolic syndrome vs EH pts (45% vs 30)
- In PA pts, genotypes 45T/G+G/G associated with significantly lower values of waist circumference, HOMA-IR and serum aldosterone
- In both PA pts and EH pts, 276T/T genotype associated with significantly worse metabolic profile and a higher risk for the metabolic syndrome
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia
Journal of Clinical Lipidology, 10/14/09
Prevalence of Unresponsiveness to Aspirin and/or Clopidogrel in Patients With Stable Coronary Heart Disease
The American Journal of Cardiology, 10/21/09
Cardiovascular diseases and risk of hip fracture
JAMA, 10/22/09
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial
Diabetic Medicine, 10/01/09
Hemoglobin A1C and diabetes diagnosis: The Rancho Bernardo Study
Diabetes Care, 10/28/09
Tests for Screening and Diagnosis of Type 2 Diabetes
Clinical Diabetes, 10/19/09
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09
Pravastatin and cardiovascular risk in moderate chronic kidney disease
Atherosclerosis, 10/07/09
Today in Obesity...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
The Lancet - Early Online Publication, 10/23/09
Increased food energy supply is more than sufficient to explain the US epidemic of obesity
American Journal of Clinical Nutrition, 10/15/09
Psychiatrists' Perceptions and Practices in Treating Patients' Obesity
Academic Psychiatry, 10/16/09
Sponsor
Article Search
Sponsor


See Latest Articles


